-
-
-
-
-
-
-
UroGen Pharma (URGN) PT Raised to $30 at D. Boral Capital
-
-
-
-
-
-
-
UroGen Pharma (URGN) PT Raised to $32 at Guggenheim
-
-
-
-
-
-
-
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages UroGen Pharma Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - URGN
-
-
-
-
-
-
-
UroGen Pharma (URGN) PT Raised to $30 at Guggenheim
-
-
-
-
-
-
-
URGN LEGAL NEWS: UroGen Pharma Ltd. Investors with Losses are Notified to Contact BFA Law about the Pending Class Action Lawsuit
-
-
-
-
-
-
-
URGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
-
-
-
-
-
-
UroGen Pharma (URGN) Announces Data at ASCO 2025 Annual Meeting on UGN-102
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

